Applied Immune Sciences Inc. of Menlo Park, Calif., named K.Frank Austen to its board of directors. He is a Harvard MedicalSchool professor and chairman of the department ofrheumatology and immunology at The Brigham and Women'sHospital.
Therapeutic Antibodies Inc. of Nashville, Tenn., named John S.Cipriano vice president of regulatory affairs and compliance.He was deputy director of the Division of BiologicalInvestigational New Drugs at the Office of Biologics of theFDA.
Kenneth W. Narducy was named president of Oculex Inc. ofMountain View, Calif. He was vice president of research anddevelopment at CooperVision.
Paracelsian Inc of Ithaca, N.Y., named Kelvin W. Welbourne vicepresident of operations. He was with Coors Biotechnology, asubsidiary of the Adolph Coors Co.
Cytogen Corp. of Princeton, N.J., named Michael M. Paulik vicepresident of operations. He was senior vice president ofoperations for Serono Laboratories Inc.
(c) 1997 American Health Consultants. All rights reserved.